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Anti-NMDA receptor (anti-NMDAR) encephalitis is a treatment-responsive autoimmune en-
cephalitis, ﬁrst described in 2007.1 Ovarian teratomas are found in one-third of the patients.2 The
clinical features of this disorder vary between patients and age groups and usually include
abnormal (psychiatric) behavior or cognitive dysfunction, speech dysfunction (pressured speech,
verbal reduction, and mutism), seizures, movement disorders, dyskinesias, or rigidity/abnormal
postures, decreased level of consciousness, autonomic dysfunction, or central hypoventilation.2
Cerebellar ataxia has been described as a symptom during the ﬁrst months of the disease,
especially in young children, in combination with other symptoms.2,3 It is extremely rare as the
initial symptom, especially in adults. We report a case of a female adult with anti-NMDAR
encephalitis presenting with cerebellar ataxia associated with recurrent mature ovarian teratomas.
Case report
A 32-year-old woman, born in South Korea and adopted at age 4 months, presented with vertigo,
nausea, and vomiting for 4 days. Her medical history consisted of bilateral cystectomy revealing
mature teratomas, discovered by ultrasound examination after a missed abortion at age 26 years.
During cesarean sections afterward (ages 29 and 31 years), no macroscopic abnormalities were
seen. Furthermore, she had had depressive symptoms, treated with venlafaxine for years.
Neurologic examination showed a horizontal gaze-evoked nystagmus to the right without other
neurologic signs or symptoms. Laboratory investigations on admission were normal, and brain
CT showed no abnormalities.
Initially, she improved after treatment with antiemetic drugs, but after 3 days, she deteriorated
quickly, also complaining of headache. Neurologic examination showed nystagmus in all
directions and dysarthric speech (cerebellar) that further worsened to impaired speech re-
stricted to one-word sentences. She showed bilateral dysmetria of the lower and especially the
upper limbs, truncal ataxia, and inability to stand and walk. Psychiatric evaluation showed rapid
progression of depressive symptoms with suicidal ideation and labile aﬀect.
BrainMRI andMRVwere normal. CSF analysis and extensive laboratory investigations showed
pleocytosis (table). Anti-NMDAR antibodies were negative in serum, but positive in CSF,4
conﬁrming the diagnosis of deﬁnite anti-NMDAR encephalitis.3
The patient was treated with IV methylprednisolone 1,000 mg (day 13, 5 days) and IV immu-
noglobulins 0.4 g/kg (day 16, 5 days). Thorax/abdomenCT and transvaginal ultrasound revealed
2 lesions in the pelvic area with fat tissue and calciﬁcations, suspect for teratomas. Bilateral
laparotomic ovariectomy was performed (day 19). Pathologic examination showed mature cystic
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teratomas, without immature components, containing nervous
tissue. Hormone replacement therapy was started.
Her neurologic condition improved within a week, but the
depressive mood remained. Recovery was hampered by uro-
sepsis, treated with cefuroxime/amoxicillin. She was treated
with a second course of methylprednisolone 4 weeks after the
initial treatment and immunoglobulins at 8 weeks for
remaining speech impairments and severe depression. This
resulted in further improvement of both. After 6 weeks, the
patient was transferred to a rehabilitation unit.
After 6 months, the patient returned home. She was able to
perform activities of daily living independently, but needed
walking aids outside due to residual ataxia and had not
returned to work (yet).
Discussion
This case with cerebellar ataxia as an initial symptom high-
lights an unusual presentation of anti-NMDAR encephalitis. If
cerebellar ataxia is present in patients with anti-NMDAR
encephalitis, it is almost exclusively found in (young) chil-
dren, and most frequently, it appears later in the disease in
combination with other symptoms.2 Diﬀerent brainstem-
cerebellar symptoms have been described, such as
opsoclonus-myoclonus syndrome, ocular movement abnor-
malities, and low cranial nerve involvement in patients with
ovarian teratomas, but these symptoms have more frequently
been described in whom no NMDAR antibodies could be
identiﬁed.5 Although 2 simultaneously occurring paraneo-
plastic neurologic syndromes, due to an ovarian teratoma,
cannot be fully excluded, this is considered unlikely. The
development of multiple symptoms quickly into diseases
compatible with anti-NMDAR encephalitis (psychiatric
symptoms and mutism), the conﬁrmation of NMDAR anti-
bodies by diﬀerent tests,4 and the identiﬁcation of an ovarian
teratoma are suitable with a diagnosis of “deﬁnite anti-
NMDAR encephalitis.”3
Although it is known that anti-NMDAR IgG antibodies bind
to granular cells in the cerebellum (but not to Purkinje cells),6
it is unknown why only approximately 5% of patients show
cerebellar complaints. MRI abnormalities of the cerebellum
have been described in 6% of patients.7 A small study showed
Table Overview of investigations
CSF analysis
White blood cells 30 × 106/L (100% mononuclear cells)
[ref: <5 × 106/L]
Protein 31 [ref: 24–49] mg/dL
Glucose 3.6 [serum: 6.4] mmol/L
Erythrocytes <5,000 × 106/L
Oligoclonal bands Present
IgG index 0.59
IgG quotient 3.1 [ref: <2.8]
PCR in liquor
HSV-1, HSV-2, VZV, EBV, enteroviruses, parechoviruses, and Borrelia Negative
Extensive laboratory investigations, among these:
TSH, anti-TPO, and vitamin E Normal
Ceruloplasmin, anti-tissue transglutaminase, anti-endomysium, and anti-GQ1b Negative
Antibodies in serum and CSF
Anti-NMDAR in serum Negative
Anti-NMDAR in CSF (cell-based assay and immunohistochemistry) Positive
Anti-Hu, anti-Yo, anti-Ri, anti-Tr, anti-amphiphysine, anti-CV2 (CRMP5), anti-Ma1, anti-Ma2, anti-GAD65,
anti-LGII, anti-Caspr2, anti-GABABR, anti-GABAAR, anti-AMPAR, and anti-DPPX
Negative
Urine analysis
Dipstick test and pregnancy test Negative
Abbreviations: anti-NMDAR = anti-NMDA receptor; anti-TPO = anti–thyroid peroxidase; EBV = Epstein-Barr virus; HSV = herpes simplex virus; TSH = thyroid-
stimulating hormone; VZV = varicella zoster virus.
Abnormal values are shown in italic font.
2 Neurology: Neuroimmunology & Neuroinflammation | Volume 6, Number 4 | July 2019 Neurology.org/NN
progressive cerebellar atrophy by follow-up MRI in 2 of 15
patients with anti-NMDAR encephalitis.6
In conclusion, cerebellar ataxia is unusual in adult patients and
an extremely rare presenting symptom of anti-NMDAR en-
cephalitis. This case shows that anti-NMDAR encephalitis
should be considered in the diﬀerential diagnosis of cerebellar
ataxia, especially in patients with previous teratomas and those
developing other symptoms shortly afterward.
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